HomeInsightsDividend

Mankind Pharma Ltd dividend

Mankind Pharma Ltd dividend

download
stocks purchased

₹ 1.2 Cr

Volume transacted

stocks purchased

5.4 K

stocks traded

Last Updated time: 18 Jul 9.00 AM

Image

Mankind Pharma Ltd

NSE: MANKIND

DPS

--

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Mankind Pharma Ltd is ₹ 0 as of 2023 .a1#The Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2019 to 0 % on March 2023 . This represents a CAGR of -100.00% over 4 years. a1#The Latest Trading Price of Mankind Pharma Ltd is ₹ 2138 as of 18 Jul 15:30 .a1#The Market Cap of Mankind Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 4 years. a1#The Revenue of Mankind Pharma Ltd changed from ₹ 2200 crore to ₹ 2535 crore over 8 quarters. This represents a CAGR of 7.36% a1#The EBITDA of Mankind Pharma Ltd changed from ₹ 476.22 crore to ₹ 685.65 crore over 8 quarters. This represents a CAGR of 19.99% a1#The Net Pr of Mankind Pharma Ltd changed from ₹ 297.64 crore to ₹ 476.59 crore over 8 quarters. This represents a CAGR of 26.54% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Mankind Pharma Ltd

Market Cap

84,714 Cr

EPS

47.8

P/E Ratio (TTM) *

44.3

P/B Ratio (TTM) *

9.1

DTE *

0.0

ROE *

20.4

ROCE *

25.4

Dividend Yield *

0

DPS *

0

Dividend Payout *

0

Ann.Dividend % *

0

* All values are consolidated

Last Updated time: 18 Jul 9.00 AM

* All values are consolidated

Last Updated time: 18 Jul 9.00 AM

×

Historical Dividend Payout of Mankind Pharma Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Mankind Pharma Ltd

Period
Mar '190
Mar '2032
Mar '210
Mar '220
Mar '230

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Mankind Pharma Ltd

NSE: MANKIND

PRICE

2138.9

24.40 (1.15%)

stock direction

Last updated : 18 Jul 15:30

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Mankind Pharma Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Mankind Pharma Ltd

Period
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in crore

×

Historical Revenue of Mankind Pharma Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Mankind Pharma Ltd

Period
Jun '222200
Sep '222457
Dec '222130
Mar '232103
Jun '232642
Sep '232772
Dec '232682
Mar '242536

* All values are a in crore

×

Historical EBITDA of Mankind Pharma Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Mankind Pharma Ltd

Period
Jun '22476
Sep '22622
Dec '22477
Mar '23467
Jun '23718
Sep '23746
Dec '23681
Mar '24686

* All values are a in crore

×

Historical Net Profit of Mankind Pharma Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Mankind Pharma Ltd

Period
Jun '22298
Sep '22423
Dec '22296
Mar '23294
Jun '23494
Sep '23511
Dec '23460
Mar '24477

* All values are a in crore

About Mankind Pharma Ltd

About Mankind Pharma Ltd

    Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products. It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory. In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind' tablets and Glimestar' tablets amongst others. It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005. It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops' and Tobastar Eye Drops'. In 2007, the Company entered the consumer healthcare segment with the launch of Manforce' brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories. It entered into the business of animal healthcare segment and launched Bandykind' and Ceftiforce'. It established their Unit II manufacturing facility at Paonta Sahib, Himachal Pradesh in year 2009. It launched the brand, Preganews' into the consumer healthcare segment in year, 2010. In 2012, it set up their first R&D centre at IMT Manesar, in Haryana. Thereafter, in year 2014, the Company acquired Shree Jee Laboratory Private Limited along with its API manufacturing site at Behror, Rajasthan. It set up the Unit II manufacturing facility at Paonta Sahib, Himachal Pradesh. In 2015, subsidiaries like Lifestar Pharma LLC in the US and Mankind Pharma Pte. Limited in Singapore were formed into with the Company. In 2017, a new manufacturing facility got established in Sikkim. In 2019, the Company entered into female infertility business segment and launched Dydroboon' tablets. In 2020, a subsidiary, Lifestar Pharmaceuticals Private Limited was formed in Nepal. The Company introduced a specialty therapeutic division for cardiovascular diseases (CVD) drugs segment and launched Cilaheart' tablets and Statpure' tablets in the market. It launched Zukanorm' tablets for diabetes pharmaceuticals segment. Another new subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE got incorporated during the year 2021. It launched Mlife' tablets in the specialty division for therapeutic respiratory pharmaceuticals. It entered into specialty therapeutic neuro/central nervous system pharmaceuticals segment business with the launch of Trugaba-NT' tablets and Prebris-MNT' tablets. In 2022, the Company acquired formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited. Further, it entered into the transplant segment with the launch of Pangraf Capsules' and Mycept' tablets. It entered into the business of oncology segment with the launch of injection Pacliall'. It acquired Daffy' and Combihale' brands from Dr. Reddy's Laboratories. The Company operate 23 manufacturing facilities across India and had 2,181 manufacturing personnel as of March 31, 2022. Their formulations manufacturing facilities have a total installed capacity of 40.77 billion units across a wide range of dosage forms including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products, as of March 31, 2022. The Company is planning to raise capital from Public by issuing 40,058,844 Equity Shares through Offer for Sale.

Mankind Pharma Ltd News Hub

News

Mankind Pharma Ltd eases for fifth straight session

Mankind Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 212...

Read more

25 Jun 202413:35

News

Mankind Pharma Ltd spurts 1.53%, rises for third straight session

Mankind Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 214...

Read more

29 May 202413:05

News

Mankind Pharma allots 46,698 equity shares under ESOP

Mankind Pharma has allotted 46,698 equity shares under ESOP on 10 May 2024. With this allo...

Read more

10 May 202409:43

News

Mankind Pharma to convene board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 15 May 2024...

Read more

08 May 202415:33

News

Mankind Pharma Ltd drops for fifth straight session

Mankind Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 220...

Read more

07 May 202413:35

News

Mankind Pharma Ltd up for five straight sessions

Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs...

Read more

26 Apr 202413:00

FAQs for dividends of Mankind Pharma Ltd

What is the current market price of Mankind Pharma Ltd Ltd as of July 18, 2024?

The current market price of Mankind Pharma Ltd Ltd stands at 2138.9 per share.

What dividend did Mankind Pharma Ltd declare in the last fiscal year?

In the last fiscal year, Mankind Pharma Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Mankind Pharma Ltd?

Mankind Pharma Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Mankind Pharma Ltd declared dividends in the current fiscal year

Mankind Pharma Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Mankind Pharma Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Mankind Pharma Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199